Emergence and evolution of a multi-host pandemic: amphibian chytridiomycosis as a model. Emerging infectious diseases are contributing to the sixth mass extinction. This study will focus on the most important disease, chytridiomycosis, which has caused the extinction of hundreds of amphibian species. It will examine the reasons for its emergence and how it is evolving - this will improve management of it and other emerging diseases.
A new approach to reversing and preventing immune-mediated diseases. Chronic inflammatory diseases affect up to 20 per cent of Australians. These diseases reduce wellbeing and life potential and shorten lifespan. This project addresses the urgent need for effective therapies and focuses on developing strategies for disease cure and prevention.
Developing a paradigm shift in new pharmaceutical and agrochemical design. This project will provide a paradigm shift in the design of new medicines and farming chemicals. The outcome of this research will be the efficient generation of diverse chemicals having real possibilities to improve global health and food security in the future.
Stress-sensing and cytoprotection in ageing and disease. This project aims to unravel the mechanisms responsible for age- and disease-related responses to heart attacks and the efficacy of therapeutic approaches, while deepening our understanding of a novel, potent protective modality effective in aged hearts. This program will provide valuable basic knowledge, leading to more efficacious therapies.
Building better Brassicas: Understanding disease resistance mechanisms across the Brassicaceae. Brassica species are important crops producing cooking oil, vegetables and biofuel, grown in diverse environments with a high economic and export value. Blackleg disease, caused by the fungus Leptospheria maculans, is the most important disease of brassica crops world-wide. The newly available brassica genome sequence provides the resources to study the co-evolution of this plant and pathogen. This pr ....Building better Brassicas: Understanding disease resistance mechanisms across the Brassicaceae. Brassica species are important crops producing cooking oil, vegetables and biofuel, grown in diverse environments with a high economic and export value. Blackleg disease, caused by the fungus Leptospheria maculans, is the most important disease of brassica crops world-wide. The newly available brassica genome sequence provides the resources to study the co-evolution of this plant and pathogen. This project will characterise the evolution and conservation of resistance genes in wild and cultivated brassicas, using next-generation sequencing technology, to assess their potential for crop improvement. An understanding of the evolution of genes responsible for resistance will lead to improved plant protection strategies for brassica crops.Read moreRead less
Development of new interventions and treatment for schistosomiasis morbidity control. Australia has played a lead role in Parasitology research. It is vital to remain at the forefront in combating the human and livestock diseases that parasites cause. Vaccine assessment and the large scale analysis of patient tissues are vital to the biotechnology, agriculture and pharmaceutical industries with outcomes leading to innovative strategies for control. Politically there is value as it is altruistic ....Development of new interventions and treatment for schistosomiasis morbidity control. Australia has played a lead role in Parasitology research. It is vital to remain at the forefront in combating the human and livestock diseases that parasites cause. Vaccine assessment and the large scale analysis of patient tissues are vital to the biotechnology, agriculture and pharmaceutical industries with outcomes leading to innovative strategies for control. Politically there is value as it is altruistic to develop new tools, technologies and treatments for the Asia/Pacific region. Economically, Australia will have first pass at developing the intellectual property arising. As well, the therapies would be developed locally to the benefit of Australia's human therapeutics industry and bio-reagent manufacturers.Read moreRead less
Be(e) friendly venomous spiders! Novel biopesticides from arachnid venoms. The overall aim of this project is to improve global honeybee health by developing novel bee-friendly bioinsecticides as well as treatments against honeybee parasites such as varroa mites and small hive beetles. This project seeks to significantly improve existing insecticidal lead peptides from spider venoms to increase their oral toxicity and make them more pest-specific. Expected outcomes of this project include a pane ....Be(e) friendly venomous spiders! Novel biopesticides from arachnid venoms. The overall aim of this project is to improve global honeybee health by developing novel bee-friendly bioinsecticides as well as treatments against honeybee parasites such as varroa mites and small hive beetles. This project seeks to significantly improve existing insecticidal lead peptides from spider venoms to increase their oral toxicity and make them more pest-specific. Expected outcomes of this project include a panel of biologically degradable venom peptides that are active against selected pest and parasite species and that can be economically produced in large scale. This would not only provide significant environmental, social and economical benefits on a global scale, but also boost the Australian agrochemical research sector.Read moreRead less
Molecular and immunological approaches to managing Australia's seafood allergy epidemic. Seafood is an increasingly important cause of food allergy. Novel insight into the functions of why and how proteins from seafood develop to potent allergens will lead to the development of better diagnostics and therapeutics. This will assist patients to better manage their serious food allergy.
Dissecting the shared genetic architecture of psychiatric and psychological traits with application to prediction of genetic risk. Identification of the early phase of psychiatric disorders is considered critical for early intervention which is the essence of prevention. At present, the main obstacle to targeted early intervention strategies in psychiatric disorders is the non-specific nature of early stage symptoms. Many psychiatric disorders present with symptoms of depressed mood and anxiety ....Dissecting the shared genetic architecture of psychiatric and psychological traits with application to prediction of genetic risk. Identification of the early phase of psychiatric disorders is considered critical for early intervention which is the essence of prevention. At present, the main obstacle to targeted early intervention strategies in psychiatric disorders is the non-specific nature of early stage symptoms. Many psychiatric disorders present with symptoms of depressed mood and anxiety in the early stages, yet best intervention treatments are dependent on the final (unknown) diagnosed disorder. Prediction of genetic risk is likely to make an important contribution for identification of individuals at risk of specific psychiatric disorders so that the best early intervention treatment can be administered. Read moreRead less
Bioactive Peptides as Pharmacological Tools and Novel Drug Leads. Bioactive peptides are produced by all organisms and play numerous critical physiological roles, including in cellular communication, host defence and capture of prey. Peptides have huge potential as tools for studying roles of signalling pathways and as novel drugs due to their high affinity and selectivity for various therapeutically relevant targets. However their use has been limited by poor in vivo stability. This project is ....Bioactive Peptides as Pharmacological Tools and Novel Drug Leads. Bioactive peptides are produced by all organisms and play numerous critical physiological roles, including in cellular communication, host defence and capture of prey. Peptides have huge potential as tools for studying roles of signalling pathways and as novel drugs due to their high affinity and selectivity for various therapeutically relevant targets. However their use has been limited by poor in vivo stability. This project is focused on studying structural features of a range of peptides and their contributions to both activity and to resistance against degradation, with the aim to develop stabilised bioactive peptide sequences for in vivo applications, allowing the full potential of peptides as drugs to be realised.Read moreRead less